Directors combine broad industry experience

Opsona Therapeutics has an active board of directors with a wealth of experience in the global pharmaceutical industry.


Manus Rogan

Dr Manus Rogan
Chairman and Investor Director

  • Managing Partner for Fountain Healthcare Partners
  • Was previously responsible for licensing Elan's products and drug development technologies in Europe and Japan
  • Joined Elan's corporate VC group in the US, where he was involved in the sourcing, screening and management of investments in private and public biotechnology companies
  • Holds an MBA from Trinity College and a PhD in chemistry 

 

Professor Luke O’Neill, Founder Director, Opsona

Professor Luke O'Neill
Founder and Independent Director

  • One of the world's foremost authorities in the innate immune system
  • Global TLR signalling opinion leader and researcher
  • Chair of European Science Foundation Immunology Panel and Professor of Biochemistry & Immunology at Trinity College Dublin

 

Bernd Seizinger

Dr Bernd Seizinger
Independent Director

  • President and Chief Executive Officer of GPC Biotech (Munich, Germany and Princeton, NJ, USA) from 1998-2009
  • Previously Vice President of Oncology Drug Discovery and - in parallel - Vice President of Corporate and Academic Alliances at Bristol-Myers Squibb
  • Is a board member of three other biotechnology companies

 

Dr. Alan O'Connell

Dr Alan O'Connell
Investor Director

  • Partner for Seroba Life Sciences
  • Former executive in product and business development pharma/ biotech industry
  • Ex-Estée Lauder Investments (New York)
  • Holds MSc (University of London) and Ph.D in pharmacology (National University of Ireland, Galway)

 

Anja Harmeier

Dr. Anja Harmeier
Investor Director

  • Investment Director at the Roche Venture Fund, Roche's CHF 500M corporate venture fund 
  • Previously held various positions at Roche early stage research and development in Neuroscience and Rare Diseases
  • PhD in Neuroscience/ Biochemistry from the Free University Berlin and MBA from ie Madrid.

 

Martin Muenchback

Dr Martin Muenchbach
Investor Director

  • Partner at BB Biotech Ventures
  • Former Investment Manager at NMT New Medical Technologies, Marketing at Sanofi-Synthelabo SA
  • MBA and PhD in Proteinchemistry ETH Zurich, Switzerland

 

Peter Bensen Investor Director Opsona

Mr Peter Benson
Investor Director

  • Managing Partner and co-founder of Sunstone Capital in Copenhagen, Denmark
  • Previously Senior Vice President, Global Head of Hospital Care at Pharmacia
  • Acted as start-up CEO, business angel and board member of more than 20 life science companies
  • Holds a B.Sc. in Business Administration from University of Lund and an M.A. Economics from University of California

 

DJA

Dr. Jan Adams
Investor Director

  • Partner at EMBL Ventures
  • Former postdoctoral Fellow of the Ernst Schering Research Foundation at the University of Granada, Spain
  • Former Fellow of the Boehringer Ingelheim Research Foundation
  • M.S. in Biochemistry & Molecular Biology from Tübingen University, Germany
  • PhD in Genetics from the University of Cambridge, UK
Learn more

Read about Opsona's management team